Blood-brain barrier alterations in human brain tumors revealed by genome-wide transcriptomic profiling
Authors:
Open Access
- 9 February 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 23 (12) , 2095-2106
Abstract
Background: Brain tumors, whether primary or secondary, have limited therapeutic options despite advances in understanding driver gene mutations and heterogeneity within tumor cells. The cellular and molecular composition of brain tumor stroma, an important modifier of tumor growth, has been less investigated to date. Only few studies have focused on the vasculature of human brain tumors despite the fact that the blood-brain barrier (BBB) represents the major obstacle for efficient drug delivery. Methods: In this study, we employed RNA sequencing to characterize transcriptional alterations of endothelial cells (EC) isolated from primary and secondary human brain tumors. We used an immunoprecipitation approach to enrich for EC from normal brain, glioblastoma (GBM), and lung cancer brain metastasis (BM). Results: Analysis of the endothelial transcriptome showed deregulation of genes implicated in cell proliferation, angiogenesis, and deposition of extracellular matrix (ECM) in the vasculature of GBM and BM. Deregulation of genes defining the BBB dysfunction module was found in both tumor types. We identified deregulated expression of genes in vessel-associated fibroblasts in GBM. Conclusion: We characterize alterations in BBB genes in GBM and BM vasculature and identify proteins that might be exploited for developing drug delivery platforms. In addition, our analysis on vessel-associated fibroblasts in GBM shows that the cellular composition of brain tumor stroma merits further investigation.Keywords
Funding Information
- Swiss Cancer League (KLS-3848-02-2016)
- Leducq Foundation (14CVD02)
- Swiss National Science Foundation (31003A_159514, 310030_188952)
- Synapsis Foundation
- Choupette Foundation (2019-PI02)
- Swiss Heart Foundation
This publication has 44 references indexed in Scilit:
- Toward determining the lifetime occurrence of metastatic brain tumors estimated from 2007 United States cancer incidence dataNeuro-Oncology, 2012
- Transcriptional profiling of human glioblastoma vessels indicates a key role of VEGF‐A and TGFβ2 in vascular abnormalizationThe Journal of Pathology, 2012
- Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase InhibitorsCancer Discovery, 2012
- Differential Gene Expression in Glioblastoma Defined by ADC Histogram Analysis: Relationship to Extracellular Matrix Molecules and SurvivalAmerican Journal of Neuroradiology, 2012
- The SLC36 family of proton‐coupled amino acid transporters and their potential role in drug transportBritish Journal of Pharmacology, 2011
- Quantitative targeted absolute proteomics of human blood–brain barrier transporters and receptorsJournal of Neurochemistry, 2011
- GDNF fusion protein for targeted‐drug delivery across the human blood–brain barrierBiotechnology and Bioengineering, 2007
- Plasmalemmal Vesicle Associated Protein-1 Is a Novel Marker Implicated in Brain Tumor AngiogenesisClinical Cancer Research, 2005
- Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma PatientsClinical Cancer Research, 2004
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971